EP1732581A4
(en )
2008-06-04
POLYPEPTIDE TRANSDUCTION AND FUSOGENIC PEPTIDES
HUP0700157A3
(en )
2009-03-02
Orally administered small peptides synergize statin activity
EP1699354A4
(en )
2011-01-05
SYSTEMS AND METHOD FOR THE DESTRUCTION OF FAT FABRICS
EP1558341A4
(en )
2010-09-08
TRANSCRIPTION FACTOR MODULATING CONNECTIONS AND THEIR USE
AU156078S
(en )
2004-08-03
Set of cannula heads
ZA200600719B
(en )
2007-03-28
Novel formulation of ropinirole
GB2388056B
(en )
2004-06-30
Synthesis of polyisoprene with neodymium catalyst
EP1652855A4
(en )
2008-11-19
POLYPEPTIDES ACTING ON PREDISPOSITIONS TO BRAIN PATHOLOGIES AND THE USE OF SAID POLYPEPTIDES
AU2003252072A8
(en )
2004-02-09
Modulation of protein kinase c-iota expression
GB2414688B
(en )
2006-12-06
System for drying gas and use of the system
AU2003285296A1
(en )
2004-05-25
Coumpounds modulating the activity of gapdh and/or iamt
EP1541174A4
(en )
2005-09-14
MEDICINE OR COSMETIC PRODUCT
IL177868A0
(en )
2006-12-31
Anti-inflammatory peptides and methods of use thereof
AU2003298582A1
(en )
2004-05-13
Therapeutic guanidines
AU2003246614A8
(en )
2004-01-19
Novel use of lipopeptide preparations
WO2004104030A3
(fr )
2005-02-10
Peptides modulateurs de l'activite du facteur de transcription engrailed
AU2003295790A8
(en )
2004-06-18
Modulation of iap-like expression
SI1625152T1
(sl )
2007-02-28
Peptidi, ki modulirajo aktivnost Engrailed transkripcijskega faktorja
HK1209050A1
(en )
2016-03-24
Survivin-derived peptides and use thereof
AU2003256931A8
(en )
2004-02-16
Uses of circadian gene mper2
EP1506218A4
(en )
2010-08-11
REVERSIBLE MODIFICATION OF THE MEMBRANE INTERACTION
AU2003295794A8
(en )
2004-06-18
Modulation of stat2 expression
AU2003296232A1
(en )
2004-07-29
A human liver regeneration associated protein and the use of it
EP1573055A4
(en )
2006-05-10
GENETIC DIAGNOSIS OF DEPRESSION
AU2003225642A1
(en )
2003-09-16
Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs